Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Find generic entry opportunities
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Method for combating virus infection|
|Abstract:||A method for the selective treatment of virus infections in animals and man and a method of treating cancer caused by viruses, comprising administering to a host so infected a therapeutically effective amount of phosphonoformic acid or a physiologically acceptable salt thereof.|
|Inventor(s):||Eriksson; Bertil F. H. (Sodertalje, SE), Helgstrand; Ake J. E. (Enhorna, SE), Misiorny; Alfons (Bandhagen, SE), Stening; Goran B. (Sodertalje, SE), Stridh; Stig A. (Sodertalje, SE)|
|Assignee:||Astra Lakemedel Aktiebolag (Sodertalje, SE)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Compound; Dosage form; Formulation;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Sweden||7607496||Jul 1, 1976|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||A465477||<disabled in preview>|
|Austria||369014||<disabled in preview>|
|Australia||510809||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.